BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7115444)

  • 1. Concurrent naproxen- and penicillamine-induced renal disease in rheumatoid arthritis.
    Quigley MR; Richfield M; Krumlovsky FA; Kanwar YS; Carone FA; Jarrett MP
    Arthritis Rheum; 1982 Aug; 25(8):1016-9. PubMed ID: 7115444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kidney involvement in rheumatoid arthritis].
    Icardi A; Araghi P; Ciabattoni M; Romano U; Lazzarini P; Bianchi G
    Reumatismo; 2003; 55(2):76-85. PubMed ID: 12874640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: D-penicillamine-induced membranous glomerulonephritis.
    Neild GH; Gärtner HV; Bohle A
    Lancet; 1975 May; 1(7917):1201-2. PubMed ID: 48830
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 5. [Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
    Trnavský K; Zbojanová M
    Fysiatr Revmatol Vestn; 1979 Apr; 57(2):87-91. PubMed ID: 570949
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural course of gold and penicillamine nephropathy: a longterm study of 54 patients.
    Hall CL
    Adv Exp Med Biol; 1989; 252():247-56. PubMed ID: 2782197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillamine nephropathy.
    Ross JH; McGinty F; Brewer DG
    Nephron; 1980; 26(4):184-6. PubMed ID: 7432580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
    Otto W; Pietruschka WD; Beenken O
    Z Gesamte Inn Med; 1975 Aug; 30(15):507-9. PubMed ID: 1189496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naproxen nephrotoxicity.
    Cartwright KC; Trotter TL; Cohen ML
    Ariz Med; 1979 Feb; 36(2):124-6. PubMed ID: 420591
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of continuing penicillamine and gold treatment on the course of penicillamine and gold nephropathy.
    Hall CL; Tighe R
    Br J Rheumatol; 1989 Feb; 28(1):53-7. PubMed ID: 2917229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis.
    Almirall J; Alcorta I; Botey A; Revert L
    Am J Nephrol; 1993; 13(4):286-8. PubMed ID: 8267029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extramembranous glomerulonephritis induced by D-penicillamine. Description of a case].
    Miguel Donderis A; Sánchez Vegazo I; Gómez Campdera FJ; Gallego JL; Fernández Fernández J; Sanz Guajardo D; Botella J
    Rev Clin Esp; 1981 Jan; 160(2):137-8. PubMed ID: 7209061
    [No Abstract]   [Full Text] [Related]  

  • 17. Naproxen-induced nephropathy in systemic lupus erythematosus.
    Ling BN; Bourke E; Campbell WG; Delaney VB
    Nephron; 1990; 54(3):249-55. PubMed ID: 2179759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent acute renal failure with interstitial nephritis due to D-penicillamine.
    Feehally J; Wheeler DC; Mackay EH; Oldham R; Walls J
    Ren Fail; 1987; 10(1):55-7. PubMed ID: 3823508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.